4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-24-007290
Options or other derivatives
- PRESIDENT AND CEO acquired 60,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Aggarwal Sumit · PRESIDENT AND CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-24 | Grant or award : show line 1 in the form Restricted Stock Units | +60,000 | 60,000 | D |
Loading xslF345X05/tm244260-1_4seq1.xml…